RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (OTCPK: LBTN) today announced that the Company has reached an agreement with Solos Endoscopy, Inc., wherein Lifeline has reacquired ownership including all rights to continue the development and marketing of the First Warning System™. The First Warning System™ is designed to assist in early detection of breast cancer.
